Clinical and molecular epidemiology of quinolone-resistant Escherichia coli isolated from urinary tract infection

Joong Sik Eom, Byong Yeon Hwang, Jang Wook Sohn, Woo Joo Kim, Ja Kim Min, Seung Chul Park, Hee-Jin Cheong

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Since the use of fluoroquinolone antibiotic in clinical practice was introduced about a decade ago, quinolone-resistant E. coli (QREC) strains are being isolated with increasing frequency. From 1996 to 2000, 297 cases of urinary tract infection (UTI) due to QREC were observed in our hospital; 218 episodes (73.5%) were community acquired. The incidence of QREC UTIs increased steadily from 14.4% to 21.3% during 5 years when we compared the clinical characteristics of 60 QREC UTI with those of 80 quinolone-susceptible E. coli UTIs. Significant differences in susceptibility to various antibiotics were observed between the QREC and QSEC strains of E. coli. The multidrug resistance rate of QREC was much higher (38.3%) than those of quinolone susceptible isolates (18.8%). Prior fluoroquinolone use (p = 0.05), old age (p = 0.001), and a vegetative state (p = 0.03) were the independent risk factors for the acquisition of QREC UTI. The outcome of E. coli UTI is dependent on quinolone resistance. Thirty-day mortality was higher in QREC UTI patients, probably due to aggravation of underlying illness, but not quinolone resistance. On the basis of PFGE analysis, although some clustering was found in the hospital, genomic diversity was found among both the community and nosocomial strains. The increased frequency of QREC UTIs is thus not due to transmission of resistant strains but probably results from the selection of resistant strains from the endogenous flora of patients.

Original languageEnglish
Pages (from-to)227-234
Number of pages8
JournalMicrobial Drug Resistance
Volume8
Issue number3
Publication statusPublished - 2002 Sep 1

Fingerprint

Molecular Epidemiology
Quinolones
Urinary Tract Infections
Escherichia coli
Fluoroquinolones
Anti-Bacterial Agents
Persistent Vegetative State
Community Hospital
Multiple Drug Resistance
Cluster Analysis

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology
  • Immunology
  • Microbiology

Cite this

Clinical and molecular epidemiology of quinolone-resistant Escherichia coli isolated from urinary tract infection. / Eom, Joong Sik; Hwang, Byong Yeon; Sohn, Jang Wook; Kim, Woo Joo; Min, Ja Kim; Park, Seung Chul; Cheong, Hee-Jin.

In: Microbial Drug Resistance, Vol. 8, No. 3, 01.09.2002, p. 227-234.

Research output: Contribution to journalArticle

@article{3f0b9f7247be4807803c0a0dccb01353,
title = "Clinical and molecular epidemiology of quinolone-resistant Escherichia coli isolated from urinary tract infection",
abstract = "Since the use of fluoroquinolone antibiotic in clinical practice was introduced about a decade ago, quinolone-resistant E. coli (QREC) strains are being isolated with increasing frequency. From 1996 to 2000, 297 cases of urinary tract infection (UTI) due to QREC were observed in our hospital; 218 episodes (73.5{\%}) were community acquired. The incidence of QREC UTIs increased steadily from 14.4{\%} to 21.3{\%} during 5 years when we compared the clinical characteristics of 60 QREC UTI with those of 80 quinolone-susceptible E. coli UTIs. Significant differences in susceptibility to various antibiotics were observed between the QREC and QSEC strains of E. coli. The multidrug resistance rate of QREC was much higher (38.3{\%}) than those of quinolone susceptible isolates (18.8{\%}). Prior fluoroquinolone use (p = 0.05), old age (p = 0.001), and a vegetative state (p = 0.03) were the independent risk factors for the acquisition of QREC UTI. The outcome of E. coli UTI is dependent on quinolone resistance. Thirty-day mortality was higher in QREC UTI patients, probably due to aggravation of underlying illness, but not quinolone resistance. On the basis of PFGE analysis, although some clustering was found in the hospital, genomic diversity was found among both the community and nosocomial strains. The increased frequency of QREC UTIs is thus not due to transmission of resistant strains but probably results from the selection of resistant strains from the endogenous flora of patients.",
author = "Eom, {Joong Sik} and Hwang, {Byong Yeon} and Sohn, {Jang Wook} and Kim, {Woo Joo} and Min, {Ja Kim} and Park, {Seung Chul} and Hee-Jin Cheong",
year = "2002",
month = "9",
day = "1",
language = "English",
volume = "8",
pages = "227--234",
journal = "Microbial Drug Resistance",
issn = "1076-6294",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Clinical and molecular epidemiology of quinolone-resistant Escherichia coli isolated from urinary tract infection

AU - Eom, Joong Sik

AU - Hwang, Byong Yeon

AU - Sohn, Jang Wook

AU - Kim, Woo Joo

AU - Min, Ja Kim

AU - Park, Seung Chul

AU - Cheong, Hee-Jin

PY - 2002/9/1

Y1 - 2002/9/1

N2 - Since the use of fluoroquinolone antibiotic in clinical practice was introduced about a decade ago, quinolone-resistant E. coli (QREC) strains are being isolated with increasing frequency. From 1996 to 2000, 297 cases of urinary tract infection (UTI) due to QREC were observed in our hospital; 218 episodes (73.5%) were community acquired. The incidence of QREC UTIs increased steadily from 14.4% to 21.3% during 5 years when we compared the clinical characteristics of 60 QREC UTI with those of 80 quinolone-susceptible E. coli UTIs. Significant differences in susceptibility to various antibiotics were observed between the QREC and QSEC strains of E. coli. The multidrug resistance rate of QREC was much higher (38.3%) than those of quinolone susceptible isolates (18.8%). Prior fluoroquinolone use (p = 0.05), old age (p = 0.001), and a vegetative state (p = 0.03) were the independent risk factors for the acquisition of QREC UTI. The outcome of E. coli UTI is dependent on quinolone resistance. Thirty-day mortality was higher in QREC UTI patients, probably due to aggravation of underlying illness, but not quinolone resistance. On the basis of PFGE analysis, although some clustering was found in the hospital, genomic diversity was found among both the community and nosocomial strains. The increased frequency of QREC UTIs is thus not due to transmission of resistant strains but probably results from the selection of resistant strains from the endogenous flora of patients.

AB - Since the use of fluoroquinolone antibiotic in clinical practice was introduced about a decade ago, quinolone-resistant E. coli (QREC) strains are being isolated with increasing frequency. From 1996 to 2000, 297 cases of urinary tract infection (UTI) due to QREC were observed in our hospital; 218 episodes (73.5%) were community acquired. The incidence of QREC UTIs increased steadily from 14.4% to 21.3% during 5 years when we compared the clinical characteristics of 60 QREC UTI with those of 80 quinolone-susceptible E. coli UTIs. Significant differences in susceptibility to various antibiotics were observed between the QREC and QSEC strains of E. coli. The multidrug resistance rate of QREC was much higher (38.3%) than those of quinolone susceptible isolates (18.8%). Prior fluoroquinolone use (p = 0.05), old age (p = 0.001), and a vegetative state (p = 0.03) were the independent risk factors for the acquisition of QREC UTI. The outcome of E. coli UTI is dependent on quinolone resistance. Thirty-day mortality was higher in QREC UTI patients, probably due to aggravation of underlying illness, but not quinolone resistance. On the basis of PFGE analysis, although some clustering was found in the hospital, genomic diversity was found among both the community and nosocomial strains. The increased frequency of QREC UTIs is thus not due to transmission of resistant strains but probably results from the selection of resistant strains from the endogenous flora of patients.

UR - http://www.scopus.com/inward/record.url?scp=0036738425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036738425&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 227

EP - 234

JO - Microbial Drug Resistance

JF - Microbial Drug Resistance

SN - 1076-6294

IS - 3

ER -